Adolore Biotherapeutics

Adolore Biotherapeutics, Inc. is a biotechnology company focused on developing new therapies for treating chronic pain and other pain-related and neurological disorders. Adolore Biotherapeutics, Inc.'s leading project is a long-acting, locally acting gene therapy, which is an opioid-free disease-modifying anti-pain therapy (DMAPs), designed to treat various chronic pain indications.